Press Release | 06.19.17 Tessa Therapeutics and Parker Institute for Cancer Immunotherapy Enter into Strategic Alliance Agreement
Press Release | 06.01.17 Parker Institute for Cancer Immunotherapy Scientists to Present Research at ASCO 2017 on IDO Pathway Inhibitors, Novel CAR-Ts and the Microbiome’s Potential in Immunotherapy
Announcement | 05.24.17 Parker Institute for Cancer Immunotherapy Bioinformatics Vice President Nikesh Kotecha to speak at Stanford Big Data conference
Research Update | 05.05.17 Autoimmunity and cancer immunotherapy: Perspective piece in Nature Medicine
Press Release | 03.28.17 Parker Institute for Cancer Immunotherapy, Bristol-Myers Squibb and the Cancer Research Institute Announce Collaboration to Accelerate Immuno-Oncology Research
Announcement, Research Update | 03.23.17 Parker Institute for Cancer Immunotherapy Scientists to Present Research on Checkpoint Inhibitors, Adoptive Cell Therapy and Other Advances in Immuno-oncology at AACR 2017
Announcement | 02.13.17 Parker Institute for Cancer Immunotherapy Named to Top 10 List of Most Innovative Companies in Biotech by Fast Company